title: New insights in AML biology from genomic analysis.
abstract: Advancements in sequencing techniques have led to the discovery of numerous genes not previously implicated in acute myeloid leukemia (AML) biology. Further in vivo studies are necessary to discern the biological impact of these mutations. Murine models, the most commonly used in vivo system, provide a physiologic context for the study of specific genes. These systems have provided deep insights into the role of genetic translocations, mutations, and dysregulated gene expression on leukemia pathogenesis. This review focuses on the phenotype of newly identified genes, including NPM1, IDH1/2, TET2, MLL, DNMT3A, EZH2, EED, and ASXL1, in mouse models and the implications on AML biology.
authors.affiliation: Massachusetts General Hospital Cancer Center, Boston, MA.
authors.forename: Ashley M
authors.initials: AM
authors.lastname: Perry
authors.affiliation: Massachusetts General Hospital Cancer Center, Boston, MA. Electronic address: eattar@partners.org.
authors.forename: Eyal C
authors.initials: EC
authors.lastname: Attar
mesh_terms: D017398:Alternative Splicing; D020732:Cytogenetic Analysis; D023281:Genomics; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*; D009154:Mutation; D000090243:Nucleophosmin